ストックスクリーナーアプリを入手
0.7959
0.75%
0.0059
アフターアワーズ：
.83
0.0341
+4.28%
前日終値:
$0.79
開ける：
$0.8018
24時間の取引高:
1.24M
Relative Volume:
1.04
時価総額：
$84.90M
収益：
$45.44M
当期純損益:
$-35.43M
株価収益率:
-2.3409
EPS:
-0.34
ネットキャッシュフロー:
$-25.39M
1週間 パフォーマンス:
+17.23%
1か月 パフォーマンス:
-31.39%
6か月 パフォーマンス:
-42.74%
1年 パフォーマンス:
-78.01%
1日の値動き範囲:
$0.75
$0.8152
1週間の範囲:
$0.66
$0.8152
52週間の値動き範囲:
$0.6434
$3.69
Maxcyte Inc Stock (MXCT) Company Profile
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.7959 | 84.27M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
114.76 | 199.24B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
384.03 | 145.93B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.65 | 124.03B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
73.48 | 111.51B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.40 | 47.82B | 6.07B | 1.06B | 799.60M | 1.8527 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | 開始されました | Stephens | Overweight |
| 2023-11-29 | 開始されました | Craig Hallum | Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | BTIG Research | Buy |
| 2021-08-24 | 開始されました | Cowen | Outperform |
| 2021-08-24 | 開始されました | Stephens | Overweight |
| 2021-08-24 | 開始されました | Stifel | Buy |
| 2021-08-24 | 開始されました | Wedbush | Outperform |
| 2021-08-24 | 開始されました | William Blair | Outperform |
すべてを表示
Maxcyte Inc (MXCT) 最新ニュース
MaxCyte unveils ExPERT DTx, a 96-well electroporation platform to accelerate discovery - marketscreener.com
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery - Finviz
Insider Buy: Is MaxCyte Inc trading at a discountJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - The Manila Times
New MaxCyte lab device runs 96 cell samples in a three-minute cycle - Stock Titan
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - The Manila Times
MaxCyte, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - Quiver Quantitative
Market Leaders: What is BEDUs book value per shareWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn
Take Profit: Is MaxCyte Inc a momentum stockJuly 2025 PostEarnings & Capital Protection Trading Alerts - baoquankhu1.vn
What are MaxCyte Inc.’s recent SEC filings showingMarket Activity Recap & Daily Profit Focused Stock Screening - mfd.ru
Dividend Watch: Is MaxCyte Inc forming a breakout patternWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Day Trade: Will MaxCyte Inc benefit from rising consumer demand2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat
Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru
Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru
Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus
Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru
Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru
Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat
MaxCyte, Inc. (NASDAQ:MXCT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat
Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn
Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Portfolio Shifts: What is the next catalyst for MaxCyte IncFed Meeting & Breakout Confirmation Alerts - baoquankhu1.vn
Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union
Published on: 2026-01-14 11:01:42 - baoquankhu1.vn
Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - The Globe and Mail
MaxCyte announces preliminary unaudited fourth quarter and full year 2025 financial results - marketscreener.com
Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results - TradingView — Track All Markets
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - Benzinga
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Recommendation of “Hold” from Brokerages - Defense World
Risk Off: Can TriNet Group Inc. stock maintain growth trajectory2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Will MaxCyte Inc. stock rally after Fed decisionsStop Loss & Weekly Market Pulse Alerts - Улправда
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - MSN
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
How strong is MaxCyte Inc. stock balance sheet2025 Performance Recap & Community Driven Trade Alerts - Улправда
Is MaxCyte Inc. stock attractive after correctionTrail vs Road Selection & walk-ready comfort choices - ulpravda.ru
Will MaxCyte Inc. stock gain from government policiesTrade Volume Report & Entry and Exit Point Strategies - Улправда
Why MaxCyte Inc. stock remains undervaluedJuly 2025 Trends & Verified Short-Term Trading Plans - Улправда
Maxcyte Inc (MXCT) 財務データ
収益
当期純利益
現金流量
EPS
0.02%
1.98%
大文字化:
|
ボリューム (24 時間):